MYL is now selling a generic version of Trizivir in emerging markets: http://finance.yahoo.com/news/Mylan-Receives-WHO-Approval-prnews-2611448371.html?x=0 I’m surprised that any docs are interested in prescribing this cocktail, even if it costs next to nothing.